Skip to content

Bio-Techne TECH Diagnostics — Operating Income

Discontinued — last reported Q4 '18

Similar metrics at other companies

Agilent Technologies logo
ADiagnostics and Genomics — Operating Income (Loss)
$94M-6.9%
Revvity logo
RVTYDiagnostics — Operating income (loss) from continuing operations
$94.65M-60.2%
Labcorp Holdings logo
LHDiagnostics — Operating Income
$458.7M+7.3%
Labcorp Holdings logo
LHLabCorp Diagnostics — Operating Income (Loss)
$378.7M-47.6%
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Income from operations
$161M+24.8%
Bio-Rad Laboratories logo
BIO.BClinical Diagnostics — Income from operations

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Bio-Techne’s 10-K, filed August 27, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does diagnostics — operating income mean?
The profit or loss earned by the diagnostics segment from its core business operations.
How do you interpret diagnostics — operating income?
An increase indicates improved operational efficiency or higher margins, while a decrease suggests rising costs or pricing pressure.
How does diagnostics — operating income compare across companies?
Operating margins in diagnostics are typically compared against industry benchmarks to assess competitive cost structures.